La nostra pipeline
Ultimo aggiornamento, luglio 2023.
| Molecule name | Indication | Discovery (advanced)/ Preclinical | Phase I | Phase II | Phase III | Registration | Geography |
|---|---|---|---|---|---|---|---|
|
Lebrikizumab
|
Atopic dermatitis
|
|
|
||||
|
Tirbanibulin
Extended label |
Actinic keratosis
|
|
|
||||
|
Sarecycline
|
Acne
|
|
|
||||
|
Efinaconazole
|
Onychomycosis
|
|
|
||||
|
Anti-IL-1RAP mAb
|
Autoinmune dermatology
|
|
|
||||
|
IL-2 mu Fc
|
Autoinmune dermatology
|
|
*
|
* Worldwide ex-Greater China